Published in Cornea on January 01, 1992
Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med (1989) 3.39
Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med (1997) 2.88
Clinical use of the 193-nm excimer laser in the treatment of corneal scars. Arch Ophthalmol (1991) 2.41
Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol (2001) 2.24
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg (1993) 2.00
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology (1996) 1.82
Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med (1986) 1.72
Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. Invest Ophthalmol Vis Sci (1983) 1.59
An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations. Am J Ophthalmol (1991) 1.50
Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res (1994) 1.46
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res (1984) 1.45
Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen (1996) 1.37
Preparation of functional smooth muscle cells from the rabbit aorta. J Exp Med (1978) 1.33
Biochemical analysis of acute and chronic wound environments. Wound Repair Regen (2006) 1.32
Antibacterial effect of cyanoacrylate glue. Arch Ophthalmol (1983) 1.31
Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg (1993) 1.29
Guinea pig pancreatic acini prepared with purified collagenase. Exp Cell Res (1980) 1.28
Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res (1994) 1.27
TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci (2000) 1.25
Serratia keratitis transmitted by contaminated eyedroppers. Am J Ophthalmol (1982) 1.23
Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res (1984) 1.19
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther (2003) 1.17
Inhibition of adenovirus replication in vitro by trifluridine. Arch Ophthalmol (1978) 1.16
Excimer laser photorefractive keratectomy in high myopia. A multicenter study. Arch Ophthalmol (1992) 1.15
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci (1997) 1.13
Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res (1998) 1.08
Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res (1997) 1.05
Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Mol Vis (2008) 1.05
Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg (1988) 1.05
Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) (2000) 1.04
Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg (1993) 1.03
Ocular anomalies simulating double optic discs. Can J Ophthalmol (1981) 1.03
Quantification of MUC2 and MUC5AC transcripts in human conjunctiva. Invest Ophthalmol Vis Sci (2000) 1.02
Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol (1979) 1.00
Effect of growth factors with dexamethasone on healing of rabbit corneal stromal incisions. Exp Eye Res (1985) 1.00
Cutaneous sarcoidal granulomas and the development of systemic sarcoidosis. Arch Dermatol (1981) 0.99
Transplantation of tissue-cultured corneal endothelium. Invest Ophthalmol Vis Sci (1978) 0.98
Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen (2000) 0.97
Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas. Invest Ophthalmol Vis Sci (1985) 0.97
Mucoepidermoid carcinoma of the conjunctiva. Arch Ophthalmol (1984) 0.95
Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab (1984) 0.95
Quantification of MUC5AC protein in human tears. Cornea (2001) 0.95
Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol (1999) 0.94
An unusual type of keratopathy observed in polyurethane workers and its reproduction in experimental animals. Am J Ind Med (1986) 0.94
Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci (1992) 0.94
Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques (1996) 0.92
The effect of air on human corneal endothelium. Am J Ophthalmol (1981) 0.92
A tissue culture assay of corneal epithelial wound closure. Invest Ophthalmol Vis Sci (1986) 0.90
Cryotherapy of Pseudomonas keratitis and scleritis. Arch Ophthalmol (1979) 0.90
Bloody tears. Am J Ophthalmol (1982) 0.89
Biological activity of an angiotensin II--ferritin conjugate on rabbit aortic smooth muscle cells. Biochemistry (1981) 0.88
Unusual superficial stromal corneal deposits in IgG kappa monoclonal gammopathy. Arch Ophthalmol (1980) 0.88
Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab (1996) 0.88
Growth factors and corneal endothelial cells: I. Stimulation of bovine corneal endothelial cell DNA synthesis by defined growth factors. Cornea (1992) 0.88
Orbital metastasis from prostatic carcinoma. Identification by an immunoperoxidase technique. Arch Ophthalmol (1981) 0.87
Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem (1999) 0.87
A gelatin membrane substrate for the transplantation of tissue cultured cells. Transplantation (1980) 0.87
Growth factors and corneal epithelium. Cornea (1988) 0.86
Pharmacological effects of topical timolol in the rabbit eye. Invest Ophthalmol Vis Sci (1980) 0.86
Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science (1977) 0.86
Transforming growth factor alpha and its receptor in neural retina. Invest Ophthalmol Vis Sci (1989) 0.85
Superior keratoconus. Refract Corneal Surg (1994) 0.85
Measurement of alpha-lactalbumin in serum and mammary tumors of rats by radioimmunoassay. Cancer Res (1977) 0.85
Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer (1995) 0.85
Enhanced short-term plasmid transfection of filtration surgery tissues. Invest Ophthalmol Vis Sci (2000) 0.85
Inhibition of proteases in Pseudomonas otitis media in chinchillas. Otolaryngol Head Neck Surg (1996) 0.85
Limbal immunopathology of Mooren's ulcer. Ann Ophthalmol (1978) 0.84
Maintenance of corneal endothelial cell shape by prostaglandin E2: effects of EGF and indomethacin. Invest Ophthalmol Vis Sci (1986) 0.84
Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod (1997) 0.84
Molecular therapy in ocular wound healing. Br J Ophthalmol (1999) 0.84
Reversal of Adriamycin-impaired wound healing by transforming growth factor-beta. Surg Gynecol Obstet (1989) 0.84
Absorption of epidermal growth factor occurs through the gastrointestinal tract and oral cavity in adult rats. Am J Physiol (1995) 0.84
Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. J Invest Dermatol (2001) 0.83
Pellucid marginal corneal degeneration: a clinicopathologic study of two cases. Exp Eye Res (1981) 0.83
Intraocular penetration of amikacin. Iris binding and bioavailability. Arch Ophthalmol (1982) 0.83
Regulation of small intestinal glutamine transport by epidermal growth factor. Surgery (1993) 0.83
Binding sites for epidermal growth factor in human fetal membranes. J Clin Endocrinol Metab (1984) 0.83
Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings. Surg Gynecol Obstet (1993) 0.83
Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest Ophthalmol Vis Sci (1996) 0.82
Rabbit corneal endothelial cells in vitro: effects of EGF. Invest Ophthalmol Vis Sci (1986) 0.82
alpha-Lactalbumin levels in human mammary tumors, sera, and mammary cell culture lines. Cancer Res (1977) 0.82
Healing after photorefractive keratectomy in cat eyes with a scanning mid-infrared Nd:YAG pumped optical parametric oscillator laser. J Refract Surg (2000) 0.81
Levels of epidermal growth factor binding in third-trimester and term human placentas: elevated binding in term placentas of male fetuses. Am J Obstet Gynecol (1987) 0.81
Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci (1992) 0.81
Transforming and epidermal growth factors in degenerated intervertebral discs. J Bone Joint Surg Br (1999) 0.81
Association of Wilms' tumor with Peter's anomaly. Ann Ophthalmol (1984) 0.81
Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-alpha antibodies and tyrphostin. Ann Surg Oncol (1997) 0.81
Double controlled comparison of IDU and trifluorothymidine in thirty-three patients with superficial herpetic keratitis. Trans Am Ophthalmol Soc (1977) 0.81
Increased binding of epidermal growth factor at preimplantation sites in mouse uteri. Endocrinology (1989) 0.81
Changes in the expression of extracellular matrix (ECM) and matrix metalloproteinases (MMP) of proliferating rat parotid acinar cells. J Dent Res (1998) 0.80
Effect of topical recombinant TGF-beta on healing of partial thickness injuries. J Surg Res (1991) 0.80
Fuchs' heterochromic cyclitis associated with subclavian steal syndrome. Ann Ophthalmol (1981) 0.80
Recurrence of keratoconus. Br J Ophthalmol (1984) 0.80
Histological comparison of corneal ablation with Er:YAG laser, Nd:YAG optical parametric oscillator, and excimer laser. J Refract Surg (2000) 0.80
Expression of alpha-smooth muscle actin, TGF-beta 1 and TGF-beta type II receptor during connective tissue contraction. In Vitro Cell Dev Biol Anim (1997) 0.80